Please ensure Javascript is enabled for purposes of website accessibility

OrganiGram CEO Steps Down

By Eric Volkman - May 3, 2021 at 7:27PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's chairman will assume Greg Engel's duties during a transitional period.

In an unexpected development, OrganiGram Holdings' (OGI 2.52%) CEO Greg Engel has vacated his position, effective Monday. In its announcement that morning, the Canadian marijuana company said that after "stepping away from his role as CEO," Engel will continue with OrganiGram as a special advisor to its board of directors through a transition period. It did not provide any detail on how long this period might last.

The company did not give a reason or reasons for Engel's departure.

A marijuana bud on fire.

Image source: Getty Images.

It did say that the board's chairman, Peter Amirault, will essentially serve as interim CEO until a permanent replacement is found. He has served as the chairman since 2017. The board's governance and nominating committee chair Geoff Machum was quoted as saying that Amirault "has deep senior and executive leadership experience in consumer packaged goods and during his tenure he has demonstrated strong governance leadership skills and excellent business acumen."

News of the CEO transition comes less than a month after OrganiGram reported its second-quarter 2021 results, which weren't exactly inspiring. Net revenue fell by a queasy 37% on a year-over-year basis, while the company's net loss deepened by a factor of nearly 10. Granted, the Canadian cannabis market has a host of daunting challenges and few of the company's peers are doing very well; still, the top-line decline and the gushing red ink are worrying developments.

It's not surprising, then, that the man at the top went to meet the ax.

Regardless, OrganiGram shareholders didn't seem to take too kindly to being blindsided by the change. They traded the stock down by 4.7% Monday; by comparison, the S&P 500 index crept up by 0.3%.

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

OrganiGram Holdings Stock Quote
OrganiGram Holdings
OGI
$0.94 (2.52%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.